Skip to main content
Livermore
Livermore
ZHEN

First Trust Advisors LP

SEC CIK
0001125816
Latest filing
Aug 11, 2026

AGIO holding history

Agios Pharmaceuticals, Inc. in every 13F filed by First Trust Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AGIO overviewAll 13F holders of AGIOFull Q2 2026 holdings

Shares (Q2 2026)
165,587
Value
$6.14M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of AGIO by First Trust Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026165,587$6.14M<0.1%+165,587NewHolders
Q1 20260$00.0%−78,656−100.0%Sold outHolders
Q4 202578,656$2.14M<0.1%+4,227+5.7%AddedHolders
Q3 202574,429$2.99M<0.1%+38,002+104.3%AddedHolders
Q2 202536,427$1.21M<0.1%−903−2.4%ReducedHolders
Q1 202537,330$1.09M<0.1%−59,929−61.6%ReducedHolders
Q4 202497,259$3.20M<0.1%−13,664−12.3%ReducedHolders
Q3 2024110,923$4.93M<0.1%−19,488−14.9%ReducedHolders
Q2 2024130,411$5.62M<0.1%+130,411NewHolders
Q1 20240$00.0%−1,818,643−100.0%Sold outHolders
Q4 20231,818,643$40.5M<0.1%+43,476+2.4%AddedHolders
Q3 20231,775,167$43.9M0.1%−385,409−17.8%ReducedHolders
Q2 20232,160,576$61.2M0.1%+322,959+17.6%AddedHolders
Q1 20231,837,617$42.2M<0.1%+206,791+12.7%AddedHolders
Q4 20221,630,826$45.8M0.1%−355,339−17.9%ReducedHolders
Q3 20221,986,165$56.2M0.1%+256,511+14.8%AddedHolders
Q2 20221,729,654$38.3M<0.1%+116,225+7.2%AddedHolders
Q1 20221,613,429$47.0M<0.1%+344,959+27.2%AddedHolders
Q4 20211,268,470$41.7M<0.1%+167,687+15.2%AddedHolders
Q3 20211,100,783$50.8M0.1%−395,313−26.4%ReducedHolders
Q2 20211,496,096$82.5M0.1%−63,405−4.1%ReducedHolders
Q1 20211,559,501$80.5M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.